Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
PMID 24464856
This makes the case especially relevant to self-funded plan sponsors
Doing so may increase the risk of side effects without providing added benefits
Similar to the findings of other studies in the STEP trial program 7,27 , exploratory outcomes showed that in the semaglutide group 80% of participants with prediabetes at baseline reverted to normoglycemia by the end of the trial (compared with 37% of those receiving placebo), while 99% of participants with normoglycemia at baseline maintained normoglycemia at the end of the trial (compared with 86% with placebo)
US$ 29.73
US$ 26.36
US$ 28.16
![Polymerization [DPYG-EN020] Super Rare](https://epikcg.com/cdn/shop/files/cd52e188-ab81-5228-9e7b-0df91a894763_800x.png?v=1721950694)
